-
1 Comment
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd is currently in a long term uptrend where the price is trading 39.2% above its 200 day moving average.
From a valuation standpoint, the stock is 380.7% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 46.3.
Based on the above factors, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| ISIN | CNE100004090 |
| CurrencyCode | CNY |
| Exchange | SHG |
| Industry | Biotechnology |
| Target Price | 205.39 |
|---|---|
| Dividend Yield | 0.2% |
| Beta | 2.12 |
| PE Ratio | 22.28 |
| Market Cap | 107B |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603392.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
